Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells (2013)

  • Authors:
  • USP affiliated authors: MORALES, ANDRESSA GOIS - IB ; QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; MACHADO, HÉLIO RUBENS - FMRP ; CARLOTTI JUNIOR, CARLOS GILBERTO - FMRP ; SERAFINI, LUCIANO NEDER - FMRP ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
  • USP Schools: IB; FMRP; FMRP; FMRP; FMRP; FMRP; FMRP; FMRP
  • DOI: 10.1007/s00381-013-2175-8
  • Subjects: PEDIATRIA; CICLO CELULAR (ANÁLISE)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00381-013-2175-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Child's Nervous System

    ISSN: 0256-7040

    Citescore - 2017: 1.21

    SJR - 2017: 0.534

    SNIP - 2017: 0.778


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2409202pcd 2409202 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MORALES, Andressa Gois; PEZUK, Julia Alejandra; BRASSESCO, María Sol; et al. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells. Child's Nervous System, Heidelberg, v. 29, n. 12, p. 2241-2248, 2013. Disponível em: < http://dx.doi.org/10.1007/s00381-013-2175-8 > DOI: 10.1007/s00381-013-2175-8.
    • APA

      Morales, A. G., Pezuk, J. A., Brassesco, M. S., Oliveira, J. C. de, Queiroz, R. G. de P., Machado, H. R., et al. (2013). BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells. Child's Nervous System, 29( 12), 2241-2248. doi:10.1007/s00381-013-2175-8
    • NLM

      Morales AG, Pezuk JA, Brassesco MS, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Neder L, Oliveira HF de, Scrideli CA, Tone LG. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells [Internet]. Child's Nervous System. 2013 ; 29( 12): 2241-2248.Available from: http://dx.doi.org/10.1007/s00381-013-2175-8
    • Vancouver

      Morales AG, Pezuk JA, Brassesco MS, Oliveira JC de, Queiroz RG de P, Machado HR, Carlotti Júnior CG, Neder L, Oliveira HF de, Scrideli CA, Tone LG. BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells [Internet]. Child's Nervous System. 2013 ; 29( 12): 2241-2248.Available from: http://dx.doi.org/10.1007/s00381-013-2175-8

    Referências citadas na obra
    Lim SK, Llaguno SRA, McKay RM, Parada LF (2011) Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. BMB reports 44(3):158–64
    Raysi Dehcordi S, De Paulis D, Marzi S, Ricci A, Cimini A, Cifone MG et al (2012) Survival prognostic factors in patients with glioblastoma: our experience. J Neurosurg Sci 56(3):239–45
    Martinez R, Esteller M (2010) The DNA methylome of glioblastoma multiforme. Neurobiol Dis 39:40–46
    Khalatbari MR, Hamidi M, Moharamzad Y (2011) Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature. Childs Nerv Syst 27:1347–1352
    MacDonald TJ, Aguilera D, Kramm CM (2011) Treatment of high-grade glioma in children and adolescents. Neuro-Oncology 1–10
    Paugh BS, Qu C, Jones C, Liu Z, Asamowicz-Brice M, Zhang J et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28(18):3061–3068
    Bax DA, Little SE, Gaspar N, Perryman L, Marshall L, Viana-Pereira M et al (2009) Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. PLoS One 4:1–9
    Hoyt MA, Totis I, Roberts BTS (1991) Cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66:507–517
    Li R, Murray AW (1991) Feedback control of mitosis in budding yeast. Cell 66:519–531
    Medina-Redondo M, Meraldi P (2009) A life outside kinetochores for Bub1 kinases? Cell Cycle 8(2):3250–3256
    Kops GJPL, Weaver BAA, Cleveland DW (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nature Reviews 5:773–785
    Musacchio A, Hardwick KG (2002) The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol 3:731–41
    Grabsch H, Takeno S, Parsons W, Pomjanski N, Boecking A, Gabbert HE et al (2003) Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in the gastric cancer—association with tumor cell proliferation. J Pathol 200:16–22
    Burum-Auensen E, DeAngelis PM, Schjolberg AR, Roislien J, Mjaland O, Clausen OPF (2008) Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorestal cancer. Cell Proliferation 41:645–659
    Pinto M, Vieira J, Ribeiro FR, Soares MJ, Henrique R, Oliveira J et al (2008) Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol 30:389–395
    Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y et al (2011) The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression. PLoS One 6(10):e25631
    Valente V, Teixeira SA, Neder L, Okamoto OK, Oba-Shinjo SM, Marie SK et al (2009) Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR. BMC Mol Biol 10:17
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 25:402–408
    Tao Y, Zhang P, Frascogna V, Lecluse Y, Auperin A, Bourhis J et al (2007) Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br J Cancer 97(12):1664–72
    Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1:2315–2319
    Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65–75
    Kirsch-Volders M, Plas G, Elhajouji A, Lukamowicz M, Gonzalez L, Loock KV et al (2011) The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch Toxicol 85(8):873–99
    Bai RY, Staedtke V, Riggins GJ (2011) Molecular targeting of glioblastoma: drug discovery and therapies. Trends in Mol Med Mar 17(6):301–12
    Kaestner P, Aigner A, Bastians H (2011) Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivo. Cancer Lett 304:128–136
    Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kondo S, Kaji M (2011) Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients. Lung Cancer 74(1):124–131
    Holland AJ, Cleveland DW (2009) Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10:478–487
    Marchetti F, Venkatachalam S (2010) The multiple roles of Bub1 in chromosome segregation during mitosis and meiosis. Cell Cycle 9(1):58–63
    Lira RCP, Miranda FA, Guimaraes MCM, Simoes RT, Donadi EA, Soares CP et al (2010) BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus. Oncol Rep 23:1027–1036
    Logarinho E, Resende T, Torres C, Bousbaa H (2008) The human spindle assembly checkpoint protein Bub3 is required for the establishment of efficient kinetochore-microtubule attachments. Mol Biol Cell 19(4):1798–813
    Pinto M, Soares MJ, Cerveira N, Henrique R, Ribeiro FR, Oliveira J et al (2007) Expression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changes. Virchows Arch 450(4):379–85
    Ando K, Kakeji Y, Kitao H, Limori M, Zhao Y, Yoshida R et al (2010) High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci 101(3):639–345
    Hsieh PC, Chen YK, Tsai KB, Shieh TY, Chang YY, Chang JG et al (2010) Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:257–267
    Ricke RM, Jeganathan KB, Deursen JM (2011) Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J Cell Biol 6:1–16
    Ouyang B, Lan Z, Meadows J, Pan H, Fukasawa K, Li W et al (1998) Human Bub1: a putative spindle checkpoint kinase closely linked to cell proliferation. Cell Growth Differ 9:877–885
    Spencer SL, Gerety RA, Pienta KJ, Forrest S (2006) Modeling somatic evolution in tumorigenesis. PLoS Comput Biol 2(8):e108, 0939–0947
    Ohgaki H, Kleihues P (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci Dec 100(12):2235–41
    Kleihues P, Burger PC, Adalpe, KD, Brat, DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, Deimling AV, Ohgak H, Cavenee WK. Gliolastoma (2007) WHO classification of tumors of the central nervous system. In: Louis DN, Ohgaki H, Wiesther OD, Cavenee WK. (Eds). International Agency for Research on Cancer, Lion, 4th ed. pp. 33–49.
    Kwiatkowski N, Jelluma N, Filippakopoulos P, Soundararajan M, Manak MS, Kwon M et al (2010) Small molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem Biol 6(5):359–368
    Kops GJPL, Foltz DR, Cleveland DW (2004) Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. PNAS 101(23):8699–8704
    Gilbert MR (2011) Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches. Semin Oncol 38(Suppl 4):S21–33
    Borges KS, Castro-Gamero AM, Moreno DA, da Silva SV, Brassesco MS, de Paula Queiroz RG et al (2012) Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. J Cancer Res Clin Oncol 138(3):405–14
    Chuah TL, Walker DG, Wei M, Scott S, Lavin MF (2012) Approaches to sensitizing glioblastoma to radiotherapy: use of lentiviral vectors. Int J Oncol 40(6):1963–9. doi: 10.3892/ijo.2012.1409
    Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD et al (2012) DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. PLoS One 7(4):e35857
    Reichert S, Reinboldt V, Hehlgans S, Efferth T, Rödel C, Rödel FA (2012) Radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother Oncol 103(3):394–401
    Yang C, Wang H, Xu Y, Brinkman KL, Ishiyama H, Wong ST et al (2012) The kinetochore protein Bub1 participates in the DNA damage response. DNA Repair (Amst) 11(2):185–91
    Kaestner P, Bastians H (2010) Mitotic drug targets. J Cell Biochem 111:258–265
    Mourón S, de Cárcer G, Seco E, Fernández-Miranda G, Malumbres M, Nebreda AR (2010) RINGO C is required to sustain the spindle-assembly checkpoint. J Cell Sci 123(Pt 15):2586–95
    Wei Y, Multi S, Yang CR, Ma J, Zhang QH, Wang ZB et al (2011) Spindle assembly checkpoint regulates mitotic cell cycle progression during preimplantation embryo development. PLoS One 6(6):e21557
    Wu YC, Yen WY, Yih LH (2008) Requirement of a functional spindle checkpoint for arsenite-induced apoptosis. J Cell Biochem 15(105(3)):678–87
    Kienitz A, Vogel C, Morales I, Muller R, Bastians H (2005) Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol. Oncogene 24:4301–4310
    Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW et al (2009) hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells. Cancer Biol Ther 8(7):627–35
    Morandi E, Severini C, Quercioli D, D’Ario G, Perdichizzi S, Capri M et al (2008) Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines. Mol Cancer 11:7–66